70 Opioid Therapy

Andrea, S. B., Gilbert, T. A., Morasco, B. J., Saha, S., & Carlson, K. F. (2020). Factors related to prescription drug monitoring program queries for veterans receiving long-term opioid therapy. Pain Medicine. https://doi.org/10.1093/pm/pnaa386

Brunet, N., Moore, D. T., Wischik, D. L., Mattocks, K. M., & Rosen, M. I. (2020). Increasing Buprenorphine access for veterans with opioid use disorder in rural clinics using telemedicine. Substance Abuse, 1–8. https://doi.org/10.1080/08897077.2020.1728466

De Aquino, J. P., Fairgrieve, C., Klaire, S., & Garcia-Vassallo, G. (2020). Rapid transition from Methadone to Buprenorphine utilizing a micro-dosing protocol in the outpatient Veteran Affairs setting. Journal of Addiction Medicine, 14(5), e271. https://doi.org/10.1097/ADM.0000000000000618

Finlay, A. K., Morse, E., Stimmel, M., Taylor, E., Timko, C., Harris, A. H. S., Smelson, D., Yu, M., Blue-Howells, J., & Binswanger, I. A. (2020). Barriers to medications for opioid use disorder among veterans involved in the legal system: A qualitative study. Journal of General Internal Medicine, 35(9), 2529–2536. https://doi.org/10.1007/s11606-020-05944-6

Gordon, A. J., Drexler, K., Hawkins, E. J., Burden, J., Codell, N. K., Mhatre-Owens, A., Dungan, M. T., & Hagedorn, H. (2020). Stepped care for opioid use disorder train the trainer (SCOUTT) initiative: Expanding access to medication treatment for opioid use disorder within Veterans Health Administration facilities. Substance Abuse, 41(3), 275–282. https://doi.org/10.1080/08897077.2020.1787299

Iheanacho, T., Payne, K., & Tsai, J. (2020). Mobile, community-based Buprenorphine treatment for veterans experiencing homelessness with opioid use disorder: A pilot, feasibility study. The American Journal on Addictions, 29(6), 485–491. https://doi.org/10.1111/ajad.13055

Jones, J., Tierney, M., Jacobs, G., Chien, S.-Y., & Mallisham, S. (2020). Empowering psychiatric mental health nurse practitioners to expand treatment opportunities for veterans with opioid use disorder. Journal of Addictions Nursing, 31(4), 261–268. https://doi.org/10.1097/JAN.0000000000000366

Manhapra, A., Stefanovics, E., & Rosenheck, R. (2020). Initiating opioid agonist treatment for opioid use disorder nationally in the Veterans Health Administration: Who gets what? Substance Abuse, 41(1), 110–120. https://doi.org/10.1080/08897077.2019.1640831

Oliva, E. M., Bowe, T., Manhapra, A., Kertesz, S., Hah, J. M., Henderson, P., Robinson, A., Paik, M., Sandbrink, F., Gordon, A. J., & Trafton, J. A. (2020). Associations between stopping prescriptions for opioids, length of opioid treatment, and overdose or suicide deaths in US veterans: Observational evaluation. BMJ, 368, m283. https://doi.org/10.1136/bmj.m283

Priest, K. C., McCarty, D., & Lovejoy, T. I. (2020). Expanding access to medications for opioid use disorder: Program and policy approaches from outside the Veterans Health Administration. Journal of General Internal Medicine, 35(3), 886–890. https://doi.org/10.1007/s11606-020-06266-3

Raines, A. M., Allan, N. P., McGrew, S. J., Gooch, C. V., Wyatt, M., Laurel Franklin, C., & Schmidt, N. B. (2020). A computerized anxiety sensitivity intervention for opioid use disorders: A pilot investigation among veterans. Addictive Behaviors, 104, 106285. https://doi.org/10.1016/j.addbeh.2019.106285

Riblet, N. B., Gottlieb, D. J., Shiner, B., Cornelius, S. L., & Watts, B. V. (2020). Associations between medication assisted therapy services delivery and mortality in a national cohort of veterans with posttraumatic stress disorder and opioid use disorder. Journal of Dual Diagnosis, 16(2), 228–238. https://doi.org/10.1080/15504263.2019.1701218